Gallagher Neil bought SNDX
February 7, 2024 · Form 4 insider transaction
Gallagher Neil bought 34,688 shares of Syndax Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,688
Price
$0.00
Total value
N/A
InsiderGallagher Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2024
Filing dateFebruary 9, 2024
Shares owned after34,688
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested.